- Home
- AIP vs SLRN Comparison
AIP vs SLRN Comparison
Compare AIP & SLRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AIP
- SLRN
- Stock Information
- Founded
- AIP 2003
- SLRN 2020
- Country
- AIP United States
- SLRN United States
- Employees
- AIP N/A
- SLRN N/A
- Industry
- AIP Semiconductors
- SLRN Biotechnology: Pharmaceutical Preparations
- Sector
- AIP Technology
- SLRN Health Care
- Exchange
- AIP Nasdaq
- SLRN Nasdaq
- Market Cap
- AIP 277.9M
- SLRN 309.0M
- IPO Year
- AIP 2021
- SLRN 2023
- Fundamental
- Price
- AIP $11.48
- SLRN $1.99
- Analyst Decision
- AIP Strong Buy
- SLRN Hold
- Analyst Count
- AIP 4
- SLRN 5
- Target Price
- AIP $13.00
- SLRN $9.60
- AVG Volume (30 Days)
- AIP 362.4K
- SLRN 1.6M
- Earning Date
- AIP 02-18-2025
- SLRN 11-13-2024
- Dividend Yield
- AIP N/A
- SLRN N/A
- EPS Growth
- AIP N/A
- SLRN N/A
- EPS
- AIP N/A
- SLRN N/A
- Revenue
- AIP $54,739,000.00
- SLRN N/A
- Revenue This Year
- AIP $8.13
- SLRN N/A
- Revenue Next Year
- AIP $19.08
- SLRN N/A
- P/E Ratio
- AIP N/A
- SLRN N/A
- Revenue Growth
- AIP 4.53
- SLRN N/A
- 52 Week Low
- AIP $5.03
- SLRN $1.91
- 52 Week High
- AIP $12.64
- SLRN $8.89
- Technical
- Relative Strength Index (RSI)
- AIP 61.08
- SLRN 27.77
- Support Level
- AIP $10.50
- SLRN $1.96
- Resistance Level
- AIP $12.13
- SLRN $2.19
- Average True Range (ATR)
- AIP 0.82
- SLRN 0.26
- MACD
- AIP -0.04
- SLRN -0.05
- Stochastic Oscillator
- AIP 59.55
- SLRN 3.92
About AIP Arteris Inc.
Arteris Inc is a developer of on-chip interconnect fabric technology designed for a variety of devices and in the development and distribution of Network-on-Chip (NoC) interconnect intellectual property (IP). The company's technology is used in System-on-Chip (SoC) and provides software and services to automate SoC integration, enabling users to efficiently deploy NoC IP, and offer IP support, maintenance services, professional services, and training and on-site support services. The company operates in Americas, Asia Pacific and Europe, Middle East, out of which it derives maximum profit from Asia Pacific.
About SLRN ACELYRIN INC.
Acelyrin Inc is a late-stage clinical biopharmaceutical company. It is focused on providing patients life-changing new treatment options by identifying, acquiring, and accelerating development and commercialization of of transformative medicines.